Source: Trial Site News
Recently, TrialSite discovered from readers that in the Central American nation of El Salvador, the nation’s Ministry of Public Health (Ministerio de Salud Publica—MINSAL) had embraced the anti-parasitic drug ivermectin as part of a combination of recommendations for early-onset treatment of COVID-19 via an ambulatory home patient kit. Such action is similar to the approach successfully executed in the Indian state of Uttar Pradesh.
The Protocol
Called the “Outpatient Treatment for COVID-19, the protocol includes the following:
| Medicines | Dose/Duration |
| Acetaminophen | 500 MG 1 Tab VO C/6 hours |
| Loratadine | 10 MG 1 Tab V C/12 hours |
| Zinc | 50 MG 1 Tab VO/ day |
| Ivermectin | 6 MG 1 Tab VO C/12 day |
| Vitamin C | 500 MG 1 Tab VO C/day |
| Vitamin D | 2000 MG 1 Tab VO C/day |
| Azithromycin | 1 Tab VO C/day |
COVID-19 Updates
With about 94,000 cases, El Salvador reports 2,872 deaths from COVID-19. Concerns grew just recently as the Health Minister reported the first Delta variant case detected in the country. The number of cases has been on the rise, with a recent spike in newly reported deaths.
TrialSite has emerged as the first digital media, social network, and research-focused information exchange platform dedicated to transparent, open, and accessible clinical research worldwide.
Related:
‘It’s crystal clear’: Professor Robert Clancy backs ivermectin as a COVID-19 treatment
USA: Omaha Doctor Sees Tremendous Success with Ivermectin as Early Treatment Against COVID-19
Study: Ivermectin can lead to “large reductions” in Covid-19 deaths